| Page 1260 | Kisaco Research
 

Kerry Briggs

Head of Medical
Kinneir Dufort

Kerry Briggs

Head of Medical
Kinneir Dufort

Kerry Briggs

Head of Medical
Kinneir Dufort
 

Matthieu Vallin

VC Investor
Octopus Ventures

Matthieu Vallin joined Octopus Ventures in 2020 and focuses on sourcing and qualifying early-stage investments that will transform healthcare and life sciences. From consumer health through to advances in drug discovery, he liaises with entrepreneurs who have a drive to bring the most benefits to the delivery of care and patient outcomes.

Matthieu Vallin

VC Investor
Octopus Ventures

Matthieu Vallin

VC Investor
Octopus Ventures

Matthieu Vallin joined Octopus Ventures in 2020 and focuses on sourcing and qualifying early-stage investments that will transform healthcare and life sciences. From consumer health through to advances in drug discovery, he liaises with entrepreneurs who have a drive to bring the most benefits to the delivery of care and patient outcomes.

 

Eileen Buttimer

Senior Vice President
Sagentia Innovation

Eileen Buttimer is Senior Vice President of New Business Development at Sagentia Innovation and has over 20 years’ experience exploring innovation opportunities with clients across multiple sectors including consumer health, pharma and med tech.  She is particularly passionate about driving innovation in the Women’s Health space.  Eileen is a strong professional skilled in International Business, Innovation Management, Entrepreneurship and Market Analysis.  She holds a PhD in Biochemistry and an MBA and prior to Sagentia Innovation, she has held R&D management positions in DuPont

Eileen Buttimer

Senior Vice President
Sagentia Innovation

Eileen Buttimer

Senior Vice President
Sagentia Innovation

Eileen Buttimer is Senior Vice President of New Business Development at Sagentia Innovation and has over 20 years’ experience exploring innovation opportunities with clients across multiple sectors including consumer health, pharma and med tech.  She is particularly passionate about driving innovation in the Women’s Health space.  Eileen is a strong professional skilled in International Business, Innovation Management, Entrepreneurship and Market Analysis.  She holds a PhD in Biochemistry and an MBA and prior to Sagentia Innovation, she has held R&D management positions in DuPont and Pfizer.

 

Avi Gesser

Partner
Debevoise and Plimpton

Avi Gesser

Partner
Debevoise and Plimpton

Avi Gesser

Partner
Debevoise and Plimpton
 

Shannon Altimari

Global Head of Oncology Advocacy to Outcomes
GSK

Shannon joined GSK in 2020 as the company’s Global Head of Oncology Advocacy to Outcomes. In this role, she leads GSK’s oncology patient advocacy strategies, with a focus on improving outcomes and supporting equitable access for patients. Prior to GSK, she was with TESARO Bio GmbH as Head of International Corporate Affairs. Before TESARO, she spent 10 years with Biogen. She is an American citizen currently living in Switzerland.

Shannon Altimari

Global Head of Oncology Advocacy to Outcomes
GSK

Shannon Altimari

Global Head of Oncology Advocacy to Outcomes
GSK

Shannon joined GSK in 2020 as the company’s Global Head of Oncology Advocacy to Outcomes. In this role, she leads GSK’s oncology patient advocacy strategies, with a focus on improving outcomes and supporting equitable access for patients. Prior to GSK, she was with TESARO Bio GmbH as Head of International Corporate Affairs. Before TESARO, she spent 10 years with Biogen. She is an American citizen currently living in Switzerland.

 

Shannon Altimari

Global Head of Oncology Advocacy to Outcomes
GSK

Shannon joined GSK in 2020 as the company’s Global Head of Oncology Advocacy to Outcomes. In this role, she leads GSK’s oncology patient advocacy strategies, with a focus on improving outcomes and supporting equitable access for patients. Prior to GSK, she was with TESARO Bio GmbH as Head of International Corporate Affairs. Before TESARO, she spent 10 years with Biogen. She is an American citizen currently living in Switzerland.

Shannon Altimari

Global Head of Oncology Advocacy to Outcomes
GSK

Shannon Altimari

Global Head of Oncology Advocacy to Outcomes
GSK

Shannon joined GSK in 2020 as the company’s Global Head of Oncology Advocacy to Outcomes. In this role, she leads GSK’s oncology patient advocacy strategies, with a focus on improving outcomes and supporting equitable access for patients. Prior to GSK, she was with TESARO Bio GmbH as Head of International Corporate Affairs. Before TESARO, she spent 10 years with Biogen. She is an American citizen currently living in Switzerland.

 
Livestock Supply Chain Connect 2023
20-21 Sep 2023
London, UK
Improve your production efficiency, sustainability and profitability through business-critical insights to overcome the biggest challenges facing our industry and counteract rising costs across Europe. Efficiently connect across your supply chain by meeting senior executives from across the meat, dairy and aquaculture supply chains across 2 days of prescheduled 1-2-1 meetings and interactive networking opportunities Discover the latest large scale, innovative solutions ready to be implemented across your supply chain at our executive panels and presentations from figureheads who are keen to connect to share their knowledge and solutions.  
Zama: Programmable Bootstrapping Enables Efficient Homomorphic Inference of Deep Neural Networks
 
AI Driven Drug Discovery Summit
18-20 Nov 2025
Boston, United States
 

Maria del Pilar Diaz Gonzalez

CEO at FemTech
MAS Holdings

Pilar is a global and multi-cultural business senior executive with 20+ years of experience in the consumer goods industry. She started her career in Spain where she is originally from, and later spanning multiple geographic locations across USA, Italy, Portugal, Switzerland and Germany. She built her career with a focus on Strategy, Marketing, Innovation and Commercialization.

Maria del Pilar Diaz Gonzalez

CEO at FemTech
MAS Holdings

Maria del Pilar Diaz Gonzalez

CEO at FemTech
MAS Holdings

Pilar is a global and multi-cultural business senior executive with 20+ years of experience in the consumer goods industry. She started her career in Spain where she is originally from, and later spanning multiple geographic locations across USA, Italy, Portugal, Switzerland and Germany. She built her career with a focus on Strategy, Marketing, Innovation and Commercialization. Pilar is currently the CEO at FemTech at MAS Holdings, the largest and leading design-to-delivery apparel solutions provider in South Asia. In her own words, she is "passionate about helping shape the future of FemHealth, an industry with massive growth potential that has been long neglected. Very proud to work with people who dare to break the taboos surrounding female intimate health and wellness, and support women through the ups and downs, the glory, and the pain, of every stage in their lives